Pleomorphic adenoma diagnostic study of choice: Difference between revisions
| Line 7: | Line 7: | ||
=== Study of choice === | === Study of choice === | ||
* | *MRI is the preferred diagnostic study of choice for pleomorphic adenoma.<ref name="RaiRohit2013">{{cite journal|last1=Rai|first1=Shalu|last2=Rohit|first2=Malik|last3=Kaur|first3=Mandeep|last4=Mukul|first4=Prabhat|title=Pleomorphic adenoma: Choice of radiographic imaging modality - Computed tomography or magnetic resonance imaging? Illustration through a case report|journal=Dental Hypotheses|volume=4|issue=1|year=2013|pages=33|issn=2155-8213|doi=10.4103/2155-8213.110181}}</ref> | ||
==== The comparison of various diagnostic studies for [disease name] ==== | ==== The comparison of various diagnostic studies for [disease name] ==== | ||
{| | {| | ||
| Line 22: | Line 20: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |...% | | style="background: #DCDCDC; padding: 5px; text-align: center;" |...% | ||
|- | |- | ||
! style="background: #696969; color: #FFFFFF; text-align: center;" | | ! style="background: #696969; color: #FFFFFF; text-align: center;" |CT | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" | | | style="background: #DCDCDC; padding: 5px; text-align: center;" | | ||
|} | |} | ||
<small> [Name of test with higher sensitivity and specificity] is the preferred investigation based on the sensitivity and specificity</small> | <small> [Name of test with higher sensitivity and specificity] is the preferred investigation based on the sensitivity and specificity</small> | ||
| Line 30: | Line 28: | ||
===== Diagnostic results ===== | ===== Diagnostic results ===== | ||
======MRI====== | ======MRI====== | ||
*MRI is the imaging modality of choice for pleomorphic adenoma.<ref name="pmid8881252">{{cite journal |vauthors=Ikeda K, Katoh T, Ha-Kawa SK, Iwai H, Yamashita T, Tanaka Y |title=The usefulness of MR in establishing the diagnosis of parotid pleomorphic adenoma |journal=AJNR Am J Neuroradiol |volume=17 |issue=3 |pages=555–9 |date=March 1996 |pmid=8881252 |doi= |url=}}</ref> | *MRI is the imaging modality of choice for pleomorphic adenoma.<ref name="pmid8881252">{{cite journal |vauthors=Ikeda K, Katoh T, Ha-Kawa SK, Iwai H, Yamashita T, Tanaka Y |title=The usefulness of MR in establishing the diagnosis of parotid pleomorphic adenoma |journal=AJNR Am J Neuroradiol |volume=17 |issue=3 |pages=555–9 |date=March 1996 |pmid=8881252 |doi= |url=}}</ref><ref name="RaiRohit2013">{{cite journal|last1=Rai|first1=Shalu|last2=Rohit|first2=Malik|last3=Kaur|first3=Mandeep|last4=Mukul|first4=Prabhat|title=Pleomorphic adenoma: Choice of radiographic imaging modality - Computed tomography or magnetic resonance imaging? Illustration through a case report|journal=Dental Hypotheses|volume=4|issue=1|year=2013|pages=33|issn=2155-8213|doi=10.4103/2155-8213.110181}}</ref> | ||
*On T1-weighted images: | *On T1-weighted images: | ||
** Pleomorphic adenoma's show homogeneous intensity. <ref name="HisatomiAsaumi2003">{{cite journal|last1=Hisatomi|first1=Miki|last2=Asaumi|first2=Jun-ichi|last3=Yanagi|first3=Yoshinobu|last4=Konouchi|first4=Hironobu|last5=Matsuzaki|first5=Hidenobu|last6=Honda|first6=Yasutoshi|last7=Kishi|first7=Kanji|title=Assessment of pleomorphic adenomas using MRI and dynamic contrast enhanced MRI|journal=Oral Oncology|volume=39|issue=6|year=2003|pages=574–579|issn=13688375|doi=10.1016/S1368-8375(03)00040-X}}</ref> | ** Pleomorphic adenoma's show homogeneous intensity. <ref name="HisatomiAsaumi2003">{{cite journal|last1=Hisatomi|first1=Miki|last2=Asaumi|first2=Jun-ichi|last3=Yanagi|first3=Yoshinobu|last4=Konouchi|first4=Hironobu|last5=Matsuzaki|first5=Hidenobu|last6=Honda|first6=Yasutoshi|last7=Kishi|first7=Kanji|title=Assessment of pleomorphic adenomas using MRI and dynamic contrast enhanced MRI|journal=Oral Oncology|volume=39|issue=6|year=2003|pages=574–579|issn=13688375|doi=10.1016/S1368-8375(03)00040-X}}</ref> | ||
Revision as of 18:38, 17 January 2019
|
Pleomorphic adenoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pleomorphic adenoma diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Pleomorphic adenoma diagnostic study of choice |
|
Risk calculators and risk factors for Pleomorphic adenoma diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Diagnostic Study of Choice
Study of choice
- MRI is the preferred diagnostic study of choice for pleomorphic adenoma.[1]
The comparison of various diagnostic studies for [disease name]
| Test | Sensitivity | Specificity |
|---|---|---|
| MRI | ...% | ...% |
| CT |
[Name of test with higher sensitivity and specificity] is the preferred investigation based on the sensitivity and specificity
Diagnostic results
MRI
- MRI is the imaging modality of choice for pleomorphic adenoma.[2][1]
- On T1-weighted images:
- Pleomorphic adenoma's show homogeneous intensity. [3]
- On T2-weighted images:
- On Gd-T1weighted images:
- It shows heterogeneous enhancement.[3]
Sequence of Diagnostic Studies
The [name of investigation] must be performed when:
- The patient presented with symptoms/signs 1, 2, and 3 as the first step of diagnosis.
- A positive [test] is detected in the patient, to confirm the diagnosis.
OR
The various investigations must be performed in the following order:
- [Initial investigation]
- [2nd investigation]
Name of Diagnostic Criteria
It is recommended that you include the criteria in a table. Make sure you always cite the source of the content and whether the table has been adapted from another source.
[Disease name] is primarily diagnosed based on clinical presentation. There are no established criteria for the diagnosis of [disease name].
OR
There is no single diagnostic study of choice for [disease name], though [disease name] may be diagnosed based on [name of criteria] established by [...].
OR
The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].
OR
The diagnosis of [disease name] is based on the [criteria name] criteria, which includes [criterion 1], [criterion 2], and [criterion 3].
OR
[Disease name] may be diagnosed at any time if one or more of the following criteria are met:
- Criteria 1
- Criteria 2
- Criteria 3
OR
IF there are clear, established diagnostic criteria
The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].
OR
The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].
OR
The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].
OR
IF there are no established diagnostic criteria
There are no established criteria for the diagnosis of [disease name].
References
- ↑ 1.0 1.1 Rai, Shalu; Rohit, Malik; Kaur, Mandeep; Mukul, Prabhat (2013). "Pleomorphic adenoma: Choice of radiographic imaging modality - Computed tomography or magnetic resonance imaging? Illustration through a case report". Dental Hypotheses. 4 (1): 33. doi:10.4103/2155-8213.110181. ISSN 2155-8213.
- ↑ Ikeda K, Katoh T, Ha-Kawa SK, Iwai H, Yamashita T, Tanaka Y (March 1996). "The usefulness of MR in establishing the diagnosis of parotid pleomorphic adenoma". AJNR Am J Neuroradiol. 17 (3): 555–9. PMID 8881252.
- ↑ 3.0 3.1 Hisatomi, Miki; Asaumi, Jun-ichi; Yanagi, Yoshinobu; Konouchi, Hironobu; Matsuzaki, Hidenobu; Honda, Yasutoshi; Kishi, Kanji (2003). "Assessment of pleomorphic adenomas using MRI and dynamic contrast enhanced MRI". Oral Oncology. 39 (6): 574–579. doi:10.1016/S1368-8375(03)00040-X. ISSN 1368-8375.
- ↑ 4.0 4.1 Kato H, Kawaguchi M, Ando T, Mizuta K, Aoki M, Matsuo M (August 2018). "Pleomorphic adenoma of salivary glands: common and uncommon CT and MR imaging features". Jpn J Radiol. 36 (8): 463–471. doi:10.1007/s11604-018-0747-y. PMID 29845358.